Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1602078/000107997324000008/nmra_8k.htm
April 2024
April 2024
February 2024
January 2024
December 2023
November 2023
November 2023
November 2023
Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1602078/000107997324000008/nmra_8k.htm
Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Nemaura Medical Inc..
Nemaura Medical Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2024 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 8-K Corporate News
Ticker: NMRDEvents:
CIK: 1602078
Form Type: 8-K Corporate News
Accession Number: 0001079973-24-000008
Submitted to the SEC: Wed Jan 03 2024 4:30:13 PM EST
Accepted by the SEC: Wed Jan 03 2024
Period: Wednesday, January 3, 2024
Industry: Surgical And Medical Instruments And Apparatus